Molecular Markers with Predictive and Prognostic Relevance in Lung Cancer
- PMID: 26316937
- PMCID: PMC4475585
- DOI: 10.1155/2012/729532
Molecular Markers with Predictive and Prognostic Relevance in Lung Cancer
Abstract
Lung cancer accounts for the majority of cancer-related deaths worldwide of which non-small-cell lung carcinoma alone takes a toll of around 85%. Platinum-based therapy is the stronghold for lung cancer at present. The discovery of various molecular alterations that underlie lung cancer has contributed to the development of specifically targeted therapies employing specific mutation inhibitors. Targeted chemotherapy based on molecular profiling has shown great promise in lung cancer treatment. Various molecular markers with predictive and prognostic significance in lung cancer have evolved as a result of advanced research. Testing of EGFR and Kras mutations is now a common practice among community oncologists, and more recently, ALK rearrangements have been added to this group. This paper discusses various predictive and prognostic markers that are being investigated and have shown significant relevance which can be exploited for targeted treatment in lung cancer.
Figures
Similar articles
-
Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review.JAMA. 2019 Aug 27;322(8):764-774. doi: 10.1001/jama.2019.11058. JAMA. 2019. PMID: 31454018 Review.
-
Combined analysis of rearrangement of ALK, ROS1, somatic mutation of EGFR, KRAS, BRAF, PIK3CA, and mRNA expression of ERCC1, TYMS, RRM1, TUBB3, EGFR in patients with non-small cell lung cancer and their clinical significance.Cancer Chemother Pharmacol. 2016 Mar;77(3):583-93. doi: 10.1007/s00280-016-2969-y. Epub 2016 Feb 3. Cancer Chemother Pharmacol. 2016. PMID: 26842788
-
Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches.Ther Adv Respir Dis. 2016 Apr;10(2):113-29. doi: 10.1177/1753465815617871. Epub 2015 Nov 30. Ther Adv Respir Dis. 2016. PMID: 26620497 Free PMC article. Review.
-
[Research Progress of KRAS Mutation in Non-small Cell Lung Cancer].Zhongguo Fei Ai Za Zhi. 2018 May 20;21(5):419-424. doi: 10.3779/j.issn.1009-3419.2018.05.11. Zhongguo Fei Ai Za Zhi. 2018. PMID: 29764594 Free PMC article. Review. Chinese.
-
Advanced Non-Small Cell Lung Cancer: Sequencing Agents in the EGFR-Mutated/ALK-Rearranged Populations.Am Soc Clin Oncol Educ Book. 2019 Jan;39:e187-e197. doi: 10.1200/EDBK_237821. Epub 2019 May 17. Am Soc Clin Oncol Educ Book. 2019. PMID: 31099642 Review.
Cited by
-
Perspectives on new biomarkers in gastric cancer: diagnostic and prognostic applications.World J Gastroenterol. 2014 Sep 7;20(33):11574-85. doi: 10.3748/wjg.v20.i33.11574. World J Gastroenterol. 2014. PMID: 25206265 Free PMC article. Review.
-
Identifying relationships between imaging phenotypes and lung cancer-related mutation status: EGFR and KRAS.Sci Rep. 2020 Feb 27;10(1):3625. doi: 10.1038/s41598-020-60202-3. Sci Rep. 2020. PMID: 32107398 Free PMC article.
-
Identification of Genetic Mutations in Human Lung Cancer by Targeted Sequencing.Cancer Inform. 2015 Jun 29;14:83-93. doi: 10.4137/CIN.S22941. eCollection 2015. Cancer Inform. 2015. PMID: 26244006 Free PMC article.
-
Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer.J Thorac Dis. 2014 Apr;6(4):387-98. doi: 10.3978/j.issn.2072-1439.2013.12.04. J Thorac Dis. 2014. PMID: 24688783 Free PMC article. Review.
-
Identification of Prognostic Genes and Pathways in Lung Adenocarcinoma Using a Bayesian Approach.Cancer Inform. 2020 Dec 10;16:1176935116684825. doi: 10.1177/1176935116684825. eCollection 2017. Cancer Inform. 2020. PMID: 33354107 Free PMC article.
References
-
- Tran Y., Benbatoul K., Gorse K., et al. Novel regions of allelic deletion on chromosome 18p in tumors of the lung, brain and breast. Oncogene. 1998;17(26):3499–3505. - PubMed
-
- Sherbet G. W., Lakshi M. S. The Genetics of Cancer. San Diego, Calif, USA: Academic Press; 1997.
-
- Miura I., Graziano S. L., Jin Quan Cheng, Doyle L. A., Testa J. R. Chromosome alterations in human small cell lung cancer: frequent involvement of 5q. Cancer Research. 1992;52(5):1322–1328. - PubMed
-
- Testa J. R., Siegfried J. M. Chromosome abnormalities in human non-small cell lung cancer. Cancer Research. 1992;52(9, supplement):2702s–2706s. - PubMed
-
- Jarrard D. F., Bussemakers M. J. G., Bova G. S., Isaacs W. B. Regional loss of imprinting of the insulin-like growth factor II gene occurs in human prostate tissues. Clinical Cancer Research. 1995;1(12):1471–1478. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous